XENMATRIX AB 1151010

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2018-04-25 for XENMATRIX AB 1151010 manufactured by Davol Inc., Sub. C.r. Bard, Inc..

Event Text Entries

[106582925] The doctor reporting the event reported that she wanted to make the manufacturer aware of this case. The hospital did not identify that the xenmatrix ab graft to be causing the complications experienced by the patient. At this time there is no connection that can be made between the reported post-op complication being caused by the xenmatrix ab graft. A manufacturing review that included review of sterility records was performed. No manufacturing issues associated to the reported event were found in the reviewed lot. Dhr review showed component acceptability and traceability were confirmed through incoming inspection records for traceable components used. All process steps were completed per manufacturing procedures and inspection procedures. Product passed all required inspections at both end product and subassembly levels. To date this is the only reported complaint for this production lot of (b)(4) units released for distribution in (b)(4) 2017. Infection is a known inherent risk of surgery. The warning section of the instructions-for-use states, "this device is not indicated for the treatment of infection. If an infection develops, treat the infection aggressively. " risk manager reported that if/when an internal report is processed a copy would be sent davol. Should additional information be obtained, a supplemental emdr will be submitted. Note: the information provided by bard represents all of the known information at this time. Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bard. Remains implanted.
Patient Sequence No: 1, Text Type: N, H10


[106582926] As reported, the patient is a (b)(6) boy who was born pre-term with significant medical complications. In 2015, the boy underwent a multi-visceral organ transplant. As reported, the patient rejected this organ transplant. In (b)(6) 2017 he underwent a second multi-visceral organ transplant procedure. During this procedure, a xenmatrix ab graft was implanted. The patient experienced post-op complications with fluid accumulation in the area of the graft. This was later identified as an infection at the site. The patient is reported to be in stable condition.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1213643-2018-01196
MDR Report Key7459293
Report SourceHEALTH PROFESSIONAL
Date Received2018-04-25
Date of Report2018-04-27
Date of Event2018-04-03
Date Mfgr Received2018-04-27
Device Manufacturer Date2017-02-15
Date Added to Maude2018-04-25
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactLAURA SUNDBERG
Manufacturer Street100 CROSSINGS BLVD.
Manufacturer CityWARWICK RI 02886
Manufacturer CountryUS
Manufacturer Postal02886
Manufacturer Phone4018258462
Manufacturer G1BARD SHANNON LIMITED -3005636544
Manufacturer StreetSAN GERONIMO INDUSTRIAL PARK LOT #1, ROAD #3, KM 79.7
Manufacturer CityHUMACAO PR 00791
Manufacturer CountryUS
Manufacturer Postal Code00791
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameXENMATRIX AB
Generic NamePORCINE SURGICAL MESH
Product CodePIJ
Date Received2018-04-25
Model NumberNA
Catalog Number1151010
Lot NumberHUBN0808
Device Expiration Date2018-12-28
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerDAVOL INC., SUB. C.R. BARD, INC.
Manufacturer Address100 CROSSINGS BLVD. WARWICK RI 02886 US 02886


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2018-04-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.